These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18516829)

  • 1. Panel discussion on MDR and XDR TB. Moderated by Dr. V.K. Arora.
    Arora VK; Singla R; Dhingra VK; Wares ; Prasad R; Selvakumar
    Indian J Tuberc; 2008 Apr; 55(2):104-9. PubMed ID: 18516829
    [No Abstract]   [Full Text] [Related]  

  • 2. Extensively drug-resistant tuberculosis.
    Madariaga MG; Lalloo UG; Swindells S
    Am J Med; 2008 Oct; 121(10):835-44. PubMed ID: 18823850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
    J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-resistant and extensively drug-resistant tuberculosis: The new face of an old disease.
    Ferguson LA; Rhoads J
    J Am Acad Nurse Pract; 2009 Nov; 21(11):603-9. PubMed ID: 19900222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination.
    Koenig R
    Science; 2008 Feb; 319(5865):894-7. PubMed ID: 18276863
    [No Abstract]   [Full Text] [Related]  

  • 6. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of extensively drug-resistant tuberculosis in Vladimir and Orel regions, Russia.
    Punga VV; Jakubowiak WM; Danilova ID; Somova TR; Volchenkov GV; Kazionnyy BY; Nemtsova ES; Kiryanova EV; Kourbatova EV
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1309-12. PubMed ID: 19793439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa.
    Andrews JR; Gandhi NR; Moodley P; Shah NS; Bohlken L; Moll AP; Pillay M; Friedland G; Sturm AW;
    J Infect Dis; 2008 Dec; 198(11):1582-9. PubMed ID: 18847372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensively drug resistance (XDR) tb is not always fatal.
    Jain NK; Agnihotri SP; Sharma KK; Gupta S; Gupta P
    Indian J Tuberc; 2009 Jan; 56(1):48-50. PubMed ID: 19402272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
    Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
    Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of XDR TB cases--a retrospective study from a tertiary care TB hospital.
    Myneedu VP; Visalakshi P; Verma AK; Behera D; Bhalla M
    Indian J Tuberc; 2011 Apr; 58(2):54-9. PubMed ID: 21644390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB).
    Martins M; Viveiros M; Ramos J; Couto I; Molnar J; Boeree M; Amaral L
    Int J Antimicrob Agents; 2009 May; 33(5):479-82. PubMed ID: 19155160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensively drug-resistant tuberculosis: back to the future.
    Migliori GB; Sotgiu G; Lange C; Centis R
    Eur Respir J; 2010 Sep; 36(3):475-7. PubMed ID: 20930199
    [No Abstract]   [Full Text] [Related]  

  • 17. [XDR-TB, extensively drug-resistant tuberculosis].
    Jaramillo E
    Biomedica; 2007 Dec; 27(4):473-4. PubMed ID: 18320113
    [No Abstract]   [Full Text] [Related]  

  • 18. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting human macrophages for enhanced killing of intracellular XDR-TB and MDR-TB.
    Martins M; Viveiros M; Couto I; Amaral L
    Int J Tuberc Lung Dis; 2009 May; 13(5):569-73. PubMed ID: 19383188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and predictors of outcomes in non-HIV-infected patients with extensively drug-resistant tuberculosis.
    Jeon DS; Kim DH; Kang HS; Hwang SH; Min JH; Kim JH; Sung NM; Carroll MW; Park SK
    Int J Tuberc Lung Dis; 2009 May; 13(5):594-600. PubMed ID: 19383192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.